Suppr超能文献

L. 精油对冠状病毒具有抗病毒活性。

L. Essential Oil Exhibits Antiviral Activity against Coronaviruses.

作者信息

Li Dar-Yin, Donadu Matthew G, Shue Taylor, Dangas Georgios, Athanasiadis Antonis, Lan Shuiyun, Wen Xin, Battah Basem, Zanetti Stefania, Mazzarello Vittorio, Sarafianos Stefan G, Ferrari Marco, Michailidis Eleftherios

机构信息

Laboratory of Biochemical Pharmacology, Department of Pediatrics, Center for ViroScience and Cure, Emory University School of Medicine, and Children's Healthcare of Atlanta, 1750 Haygood Drive, Atlanta, GA 30322, USA.

Scuola di Specializzazione in Farmacia Ospedaliera, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.

出版信息

Pharmaceuticals (Basel). 2024 Sep 10;17(9):1189. doi: 10.3390/ph17091189.

Abstract

Human coronaviruses are a continuous threat to the human population and have limited antiviral treatments, and the recent COVID-19 pandemic sparked interest in finding new antiviral strategies, such as natural products, to combat emerging coronaviruses. Rapid efforts in the scientific community to identify effective antiviral agents for coronaviruses remain a focus to minimize mortalities and global setbacks. In this study, an essential oil derived from L. (MEO) is effective against HCoV-229E and HCoV-OC43 virus infections in comparison to two FDA-approved drugs, Remdesivir and Nirmatrelvir. Gas-chromatography and mass spectrometry were used to identify the chemical composition of MEO. Slight antioxidant activity was observed in MEO, indicating a role in oxidative stress. A dose-response curve measuring the EC indicates a high potency against HCoV-229E and HCoV-OC43 virus infections on Huh7.5 cells with low cytotoxicity using a PrestoBlue cell viability assay. Our findings demonstrate that MEO exhibits potent antiviral activity against HCoV-229E and HCoV-OC43 on Huh7.5 cells within a low-cytotoxicity range, but not on SARS-CoV-2. Artificial bacterial chromosome plasmids that expressed SARS-CoV-2 used for replicon-to determine viral replication and viral assembly/egress on HEK293T/17 cells-and virus-like particles on Huh7.5-AT cells-to determine viral entry and assembly/egress-showed no antiviral activity with MEO in comparison to Remdesivir. This study reveals the potential effectiveness of MEO as an alternative natural remedy to treat human coronaviruses and a potential antiviral agent for future coronavirus infections.

摘要

人类冠状病毒对人类一直构成持续威胁,且抗病毒治疗手段有限,近期的新冠疫情激发了人们寻找新的抗病毒策略(如天然产物)来对抗新型冠状病毒的兴趣。科学界迅速行动,致力于识别有效的冠状病毒抗病毒药物,这仍是将死亡率和全球挫折降至最低的重点。在本研究中,与两种美国食品药品监督管理局(FDA)批准的药物瑞德西韦和奈玛特韦相比,一种从罗勒属植物中提取的精油(MEO)对人冠状病毒229E株(HCoV-229E)和人冠状病毒OC43株(HCoV-OC43)感染有效。采用气相色谱和质谱法鉴定MEO的化学成分。在MEO中观察到轻微的抗氧化活性,表明其在氧化应激中发挥作用。通过测量半数有效浓度(EC)的剂量反应曲线表明,使用普洛麦格公司的碧染细胞活力检测试剂盒,MEO在低细胞毒性的情况下对Huh7.5细胞上的HCoV-229E和HCoV-OC43病毒感染具有高效力。我们的研究结果表明,MEO在低细胞毒性范围内对Huh7.5细胞上的HCoV-229E和HCoV-OC43具有强大的抗病毒活性,但对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)无此活性。用于复制子的表达SARS-CoV-2的人工细菌染色体质粒,用于在人胚肾293T/17细胞上测定病毒复制和病毒组装/释放,以及在Huh7.5-AT细胞上测定病毒样颗粒以确定病毒进入及组装/释放,结果显示与瑞德西韦相比,MEO对上述过程均无抗病毒活性。本研究揭示了MEO作为治疗人类冠状病毒的替代天然药物以及未来冠状病毒感染潜在抗病毒药物的潜在有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验